Avoro Capital Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-119,680
Closed -$665K 57
2018
Q1
$665K Sell
119,680
-632,775
-84% -$3.92M 0.03% 50
2017
Q4
$4.91M Sell
752,455
-184,454
-20% -$1.37M 0.32% 37
2017
Q3
$8.22M Buy
936,909
+29,313
+3% +$238K 0.64% 30
2017
Q2
$7.56M Buy
907,596
+597
+0.1% +$4.87K 0.95% 26
2017
Q1
$8.33M Hold
906,999
1.06% 24
2016
Q4
$7.02M Sell
906,999
-11,557
-1% -$86.4K 1.42% 23
2016
Q3
$6.99M Hold
918,556
1.23% 24
2016
Q2
$4.62M Buy
918,556
+188,042
+26% +$1.01M 1.03% 25
2016
Q1
$3.94M Sell
730,514
-10,839
-1% -$64.1K 1.38% 22
2015
Q4
$5.34M Sell
741,353
-30,944
-4% -$208K 1.84% 18
2015
Q3
$3.62M Buy
772,297
+13,800
+2% +$131K 0.94% 22
2015
Q2
$8.45M Buy
+758,497
New +$7.47M 2.33% 12

Other funds holding VCYT

Avoro Capital Advisors's VCYT Position: Q2 2018 in Review

Avoro Capital Advisors sold out of Veracyte (VCYT) in Q2 2018, closing a stake of 119,680 shares — an estimated $665K sold.

Avoro Capital Advisors first reported a position in VCYT in Q2 2015 and held it in 12 quarters. The position peaked at $8.45M in Q2 2015. 75 funds tracked by Wall St. Rank hold VCYT as of Q2 2018.

  • Avoro Capital Advisors reported no remaining Veracyte position as of Q2 2018 after selling out during the quarter.
  • Avoro Capital Advisors sold 119,680 Veracyte shares in Q2 2018, an estimated $665K.
  • Avoro Capital Advisors first reported a position in Veracyte in Q2 2015 and held it in 12 quarters.
  • Avoro Capital Advisors's Veracyte position peaked at $8.45M in Q2 2015.
  • 75 funds tracked by Wall St. Rank held Veracyte as of Q2 2018.

Based on Avoro Capital Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.